APA (7th ed.) Citation

JS, H., EM, L., FG, H., PJ, R., RH, G., D, B., . . . CC, W. (2023). Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): Two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet (London, England), 402(10411), 1434. https://doi.org/10.1016/S0140-6736(23)01520-9

Chicago Style (17th ed.) Citation

JS, Heier, et al. "Pegcetacoplan for the Treatment of Geographic Atrophy Secondary to Age-related Macular Degeneration (OAKS and DERBY): Two Multicentre, Randomised, Double-masked, Sham-controlled, Phase 3 Trials." Lancet (London, England) 402, no. 10411 (2023): 1434. https://doi.org/10.1016/S0140-6736(23)01520-9.

MLA (9th ed.) Citation

JS, Heier, et al. "Pegcetacoplan for the Treatment of Geographic Atrophy Secondary to Age-related Macular Degeneration (OAKS and DERBY): Two Multicentre, Randomised, Double-masked, Sham-controlled, Phase 3 Trials." Lancet (London, England), vol. 402, no. 10411, 2023, p. 1434, https://doi.org/10.1016/S0140-6736(23)01520-9.